平均动脉压阈值与失代偿期肝硬化脓毒性休克临床结局的关联
这项多中心回顾性研究纳入2014至2022年德州20家医院ICU收治的1145例失代偿期肝硬化合并脓毒性休克患者,计算入院最初72小时的时间加权平均动脉压(TWA-MAP),评估其与28天死亡率及急性肾损伤(AKI)未恢复的关联。结果显示TWA-MAP从<60 mmHg升至75 mmHg与28天死亡率风险逐步降低相关,但>75 mmHg后生存获益趋于平台;AKI未恢复也呈类似关联。作者提出维持MAP在70-75 mmHg可能优化生存和肾脏恢复,需随机试验比较传统目标(60-65 mmHg)与中间目标(70-75 mmHg)。
要点
- TWA-MAP从<60 mmHg升至75 mmHg与28天死亡率风险逐步降低相关,>75 mmHg后获益趋平。
- AKI未恢复也随TWA-MAP阈值升高呈类似关联,>75 mmHg后减弱。
- 维持MAP在70-75 mmHg可能优化生存和肾脏恢复,尚需随机试验验证。
核心结论
- 在失代偿期肝硬化合并脓毒性休克患者中,维持MAP在70-75 mmHg可能与优化生存和肾脏恢复相关。
- TWA-MAP从<60 mmHg升至75 mmHg与28天死亡率及AKI未恢复风险逐步降低相关,但>75 mmHg后获益趋于平台。
- 需随机试验比较传统MAP目标(60-65 mmHg)与中间目标(70-75 mmHg)以改善该高危人群结局。
研究设计与样本
- 共纳入1145例患者,平均年龄64岁,MELD评分26,43%女性,19%非白人,22%西班牙裔,38%酒精相关性肝硬化。
- 计算入院最初72小时的时间加权平均动脉压(TWA-MAP)以量化低血压暴露。
- 采用多变量logistic回归模型评估不同TWA-MAP阈值(60-90 mmHg)对28天死亡率和AKI未恢复的影响,并调整相关混杂因素。
主要发现
- 66%患者发生AKI,其中37%未恢复;28天死亡率为56%。
- TWA-MAP从<60 mmHg升至75 mmHg与28天死亡率风险逐步降低相关:<60 mmHg OR 2.775;<65 mmHg OR 1.607;<70 mmHg OR 1.305;<75 mmHg OR 1.180。
- TWA-MAP>75 mmHg后生存获益趋于平台。
- AKI未恢复呈类似关联:<60 mmHg OR 1.151;<65 mmHg OR 1.153;<70 mmHg OR 1.110;<75 mmHg OR 1.079;>75 mmHg后减弱。
临床怎么用
- 对于失代偿期肝硬化合并脓毒性休克患者,可考虑将MAP维持在70-75 mmHg以优化生存和肾脏恢复。
- 传统MAP目标(60-65 mmHg)与中间目标(70-75 mmHg)的优劣尚需随机试验验证。
局限性
- 为回顾性研究,可能存在残余混杂。
- 仅纳入德州20家医院的患者,外推性受限。
- 需要随机试验比较传统与中间MAP目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Short-term mortality remains high in decompensated cirrhosis patients with septic shock. While a mean arterial pressure (MAP) >65 mm Hg is recommended for the management of septic shock in the general population, the optimal MAP for decompensated cirrhosis is not well defined. We evaluated the association between various MAP thresholds, 28-day mortality, and acute kidney injury (AKI) nonrecovery. METHODS: We conducted a multicenter retrospective analysis of decompensated cirrhosis patients with septic shock admitted to intensive care units across 20 Texas hospitals (January 1, 2014-December 31, 2022). Time weighted average MAP (TWA-MAP) during the initial 72 hours of admission was calculated to quantify hypotension exposure. Multivariable logistic regression models assessed the impact of various TWA-MAP thresholds (60-90 mm Hg) on 28-day mortality and AKI nonrecovery, adjusting for relevant confounders. RESULTS: Among 1,145 patients (mean age 64, Model for End-Stage Liver Disease 26, 43% female, 19% non-White, 22% Hispanic, 38% alcohol-associated cirrhosis), 66% had AKI, with 37% nonrecovery; 28-day mortality was 56%. Increasing TWA-MAP from <60 mm Hg to 75 mm Hg was associated with a stepwise reduction in the odds of 28-day mortality (<60 odds ratio [OR] 2.775; <65 OR 1.607; <70 OR 1.305; <75 OR 1.180). However, the survival benefit plateaued >75 mm Hg. Similar associations were found for AKI nonrecovery (<60 1.151; <65 OR 1.153; <70 OR 1.110; <75 OR 1.079) and reductions attenuated >75 mm Hg. DISCUSSION: Maintaining MAP between 70 and 75 mm Hg may optimize survival and kidney recovery in patients with decompensated cirrhosis and septic shock. Randomized trials are needed to compare traditional MAP targets (60-65 mm Hg) with intermediate targets (70-75 mm Hg) to improve outcomes in this high-risk population.
引用
- Patidar KR, Hall L, Ogola GO, et al. Associations Between Mean Arterial Pressure Thresholds and Clinical Outcomes in Decompensated Cirrhosis With Septic Shock. Am J Gastroenterol. 2025. PMID: 41504279. doi:10.14309/ajg.0000000000003854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。